James Kinley
Director of Finance/CFO bij ALGERNON PHARMACEUTICALS INC.
Vermogen: 106 018 $ op 31-03-2024
Profiel
James F.
Kinley is currently an Independent Director at Medicure, Inc. and the Chief Financial Officer & Director at Algernon Pharmaceuticals, Inc. He previously worked as a Principal at Ernst & Young LLP.
Additionally, he served as the Chief Financial Officer at Medicure, Inc. from 2011 to 2021 and as the Chief Financial Officer at Luminor Medical Technologies, Inc. from 2011 to 2016.
He also held a managerial position at Manitoba Telecom Services, Inc. Mr. Kinley obtained his undergraduate degree from Asper School of Business.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
05-02-2024 | 810 992 ( 4.05% ) | 66 501 $ | 31-03-2024 | |
MEDICURE INC.
0.45% | 10-04-2023 | 47 100 ( 0.45% ) | 39 517 $ | 31-03-2024 |
Actieve functies van James Kinley
Bedrijven | Functie | Begin |
---|---|---|
ALGERNON PHARMACEUTICALS INC. | Director of Finance/CFO | 01-12-2021 |
MEDICURE INC. | Director/Board Member | 16-06-2022 |
Eerdere bekende functies van James Kinley
Bedrijven | Functie | Einde |
---|---|---|
MEDICURE INC. | Director of Finance/CFO | 15-05-2021 |
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada. | Director of Finance/CFO | 18-01-2016 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
BELL MTS | Corporate Officer/Principal | - |
Opleiding van James Kinley
Asper School of Business | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
MEDICURE INC. | Health Technology |
ALGERNON PHARMACEUTICALS INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Manitoba Telecom Services, Inc.
Manitoba Telecom Services, Inc. Wireless TelecommunicationsCommunications Manitoba Telecom Services, Inc. was engaged in the provision of telecommunications services. Manitoba Telecom Services was founded in 1908 and was headquartered in Winnipeg, Canada. | Communications |
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada. | Commercial Services |